Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC6A3 |
| Upstream (Parents) |
|---|
| (<<) CA11 → SLC6A3 |
| (<<) CACNG3 → SLC6A3 |
| (<<) ICAM4 → SLC6A3 |
| (<<) PADI2 → SLC6A3 |
| (<<) TSGA14 → SLC6A3 |
| (<<) ADAM21P1///ADAM21 → SLC6A3 |
| (<<) DVL3 → SLC6A3 |
| (<<) HIST1H3H → SLC6A3 |
| Downstream (Children) |
|---|
| SLC6A3 → PSCA (>>) |
| SLC6A3 → HR44 (>>) |
| SLC6A3 → ATP6V0A4 (>>) |
| SLC6A3 → MAGEC3 (>>) |
| SLC6A3 → TSGA14 (>>) |
